Ireland: The World Anti-Doping Code Updated

Last Updated: 25 July 2019
Article by Aidan Healy

The 2021 version of the World Anti-Doping Code (the Code) is likely to be approved at the fifth World Conference on Doping in Sport, to be held in November 2019 in Katowice, Poland.

This will be the fourth rewriting of the Code and the culmination of a two-year process involving stakeholder consultation and the circulation of multiple drafts of the proposed Code amendments. 2 Simultaneously, WADA (World Anti-Doping Agency) is also introducing an International Standard for Results Management and an International Standard for Education, as well as revising its six existing international standards.3

Rather than attempt to revisit old ground4, the WADA Foundation Board has directed the Code drafting team5 to limit the scope of the review and focus primarily on new views and arguments, with the aim of making the Code more effective. While many of the proposed changes may be welcomed, the effectiveness of the Code has long been called into question and it does not appear that the changes proposed will have any substantial impact on the overall effectiveness of the Code in tackling the problem of doping in sport.

This article considers some of the concerns around the effectiveness of the Code and anti-doping generally, as well as identifying some of the issues the 2021 Code seeks to address; how it proposes to do so; and the implications for anti-doping bodies.

Underlying issues

There are long-standing concerns around the effectiveness of the World Anti-Doping Programme.

We know, for example, that just 1.43% of doping tests return a positive test (an Adverse Analytical Finding or "AAF") (and in many countries the figure is much lower), but despite the increased onus on investigations and intelligence-led testing in recent years, more and more tests are being carried out – in 2017, testing under the Code increased by 7.1%.6

The prevalence of doping in elite sport is believed to be much higher than these figures suggest. For example, a WADAcommissioned study7, based on anonymous surveys carried out at two elite athletics competitions in 2011, found that up to 57% of competitors had admitted doping in the previous twelve months. This study was not made public until 2017.

When you consider that of the 1.43% of doping tests which return a positive result, many of them relate to athletes in the lower echelons of sport (although there appear to be no readily available figures from WADA on this) or are the result of inadvertent or unintentional doping. Yet more relate to recreational drugs. This raises questions around to whom the anti-doping regime should apply; whom it is catching; and what it is catching them for. The draft 2021 Code does seem to acknowledge that some of these issues are in need of reform and it is worth examining some of these issues in more detail.

To whom do the rules apply?

The same rules and sanctions can apply to an Olympian and a once-a-week jogger. Under the current Code, while anti-doping organisations are not required to test lower- level athletes, if they do (and many do) and there is, for example, a positive test, then all of the sanctions and consequences set down in the Code apply in the same way as they would apply to an Olympian. This has been the subject of criticism, as these lower-level athletes are unlikely to have had the same anti-doping educational opportunities as higher-level athletes, and it can be argued that the implications of mandatory public disclosure on the employment status of someone, who participates in sport only at the recreational level, may be disproportionate.

Two recent examples highlight the outcomes of concern which can arise.

In New Zealand, "athlete XYZ" was recently banned for one year after his details were found on a list of customers of a man convicted of trafficking steroids online.8 Drug Free Sport New Zealand's ("DFSNZ") position appears to have been that, as a member of a surf life-saving club and a local golf club, he was bound by anti-doping rules. While the tribunal appears to have "reluctantly" found that XYZ was bound by anti-doping rules, it expressed human rights concerns at the "potentially vast regime" of DFSNZ. It ruled that DFSNZ had extended the meaning of "athlete" in its anti-doping rules to include members of local sports clubs and that it has done so "not expressly by amending the rules to make this transparent, but by an unannounced executive decision to enforce the contravention of the rules against such a person".9

DFSNZ appears to have been concerned that the ban was too lenient, and this could set an unwelcome precedent in relation to other cases. This is understandable, given that there are understood to be 20-25 cases arising from the same investigation, which are still to be prosecuted. When it comes to the precedent value of the case, it is also worth bearing in mind, that, as matters stand, the same rules apply to athlete XYZ as apply to the All Blacks. DFSNZ has appealed the decision to the Court of Arbitration for Sport (CAS) in what must surely be the first case of a local surf life-saving club member appearing before sport's highest tribunal.

The second case involves ninety-year-old US cyclist, Carl Grove, who tested positive in July 2018 at the US Masters Track National Championships, where he won the 90- 94 year-old sprint title.10 The US Anti-Doping Agency admitted that the positive test was probably due to his inadvertent consumption of  contaminated meat and, while he was not banned, he was stripped of his title and world record and issued with a public warning. 

Concerns have been expressed as to whether testing a 90-year-old is an effective use of an anti-doping organisation's resources, particularly in the light of the prevalence of doping in elite sport and the lack of antidoping education and understanding at such a level.

Others have argued that testing, at all levels in sport, is a necessity to properly discourage lower-level athletes from cheating and, of course, to catch (some of) those who do. However, a more lenient sanctioning regime may go some way towards satisfying both sides of this argument and this is what the 2021 Code proposes.

What violations are being caught?

WADA indicated, at its recent annual symposium in Lausannne, that 40-45% of AAFs are inadvertent. In other words, they are accidental and not the result of intentional doping. "Intentional doping" is defined in the current Code as conduct which the athlete knew constituted an anti-doping rule violation or knew that there was a significant risk that the conduct might constitute or result in an anti-doping rule violation and manifestly disregarded that risk. WADA's figures indicate that 44% of AAFs in 2017 were for anabolic agents.

There is no additional breakdown which might provide, for example, details of how many AAFs are found to be the result of the use of supplements or contaminated supplements. However, the WADA figures for 2017 also indicate that nearly 6% of AAFs were for cocaine and cannabis, with a further 2% for narcotics. Many anti-doping organisations have, for many years, decried the resources spent on dealing with AAFs for recreational drugs, as well the length of the bans arising from such positive tests.

The number of AAFs for cannabis has fallen significantly in recent years, due to WADA changing the testing criteria. The current threshold for cannabis is 150 ng/mL in urine.11  This means that findings of cannabis below this level are not deemed to be positive tests and are not reported as AAFs. Until 2013, the threshold was 15 ng/mL and the rationale for WADA to significantly increase the threshold was to ensure that the in-competition consumption of cannabis continued to be detected but that use in the days and weeks before a competition would not necessarily be detected.12

As matters stand, athletes who test positive for cannabis are automatically entitled to a reduced ban based on the ground of "No Significant Fault or Negligence", if they can demonstrate that it was used in a context unrelated to sport performance.13 Cannabis is classified as a "Specified Substance" and these two factors combined mean that an athlete can avail himself/herself of art. 10.5.1 of the Code, which provides for a reprimand and no ban, up to a two  year ban, depending on the athlete's degree of fault.14 

The level of sanction attracted by cocaine has been a bone of contention in recent years. Cocaine is banned in-competition only, meaning that it is not a violation to test positive for cocaine out of competition.

Cocaine is a non-specified substance, placing it in the same category as anabolic steroids, EPO and human growth hormone. The ban for cocaine is between twelve months and four years, unless the athlete can show "No Fault or Negligence" (which is extremely unlikely). In most cases, the upper limit of the ban will be two years, if an athlete can establish that the violation was not taken out-ofcompetition in a context unrelated to sport performance.15

However, the length of the ban in a cocaine case can attract a great deal of legal argument, as the ADRV can arise from taking cocaine out-of-competition (when it is not banned) and then competing in an event before it has left your system.16 However, many athletes test positive for benzoylecgonine, a metabolite for cocaine, which can often remain in your system for 2-5 days after taking cocaine.

Another concern in relation to the type of violations being caught is in relation to findings of minute concentrations of prohibited substances. As has been pointed out by Markus Manninen recently17, WADAaccredited laboratories are able to detect infinitesimally small quantities of prohibited substances – recent cases have involved the detection of prohibited substances in such quantities as 0.5 ng/mL (nanograms per millilitre). One nanogram is a billionth of a gram. Many athletes make the case that such a small quantity could not have affected their sporting performance and should not be regarded as cheating. Equally, such tiny quantities of a prohibited substance may arise from contamination, from a variety of sources of food, supplements, tap water or even from a kiss.18 While this ability to detect miniscule quantities of prohibited substances in athlete samples has made it easier to detect the tail end of the intentional use of a prohibited substance, it also increased the likelihood
that an AAF will result from contamination of a supplement or other product. The current Code provides that, in order for an athlete to receive a reduced sanction on account of a contaminated product, the athlete must be able to identify the contaminated product which he or she consumed that caused the AAF.19

However, it can be extremely difficult, if not impossible, for an athlete to identify the source of such a concentration of a prohibited substance, thus making it more difficult to avail of a reduced sanction based on, for example, "No Significant Fault or Negligence". It can, in some cases, be extremely difficult to do so.

A related issue is the problem of substances, which are not prohibited out-of-competition, appearing, in trace amounts, in in-competition samples. This has become increasingly problematic as laboratories can often detect substances which were obviously used out-of-competition and could not possibly have had an in-competition effect.

2021 Code

How does the 2021 Code propose to address some of these issues?

Detection of minute traces The WADA drafting team has decided that, rather than modify the rule in the current Code relating to contaminated products, a better approach would be to raise the reporting limits for those prohibited substances which are known contaminants. It is understood that the WADA List Committee is working on an approach in this regard.

As regards detecting substances not prohibited out-of competition in trace amount in in-competition samples, it is proposed that the WADA List Committee will consider reporting thresholds for certain substances. 

Substances of abuse

During the consultation process, which led to the 2015 Code, WADA had considered creating a "substances of abuse" category that would have included cocaine and carried with it a sanction range of a reprimand up to twelve months. This proposal was ultimately rejected.

This time, however, it does seem that a similar proposal will get over the line. Following significant stakeholder
feedback after draft 1 of the 2021 Code was circulated, WADA has proposed revisions to the Code, which would allow the WADA List Committee to categorise those substances on the Prohibited List, which are often abused in society outside sport as "Substances of Abuse." If an athlete can establish that he or she took a substance of abuse out-of-competition and unrelated to sport performance, a ban of three months would apply – there would be no legal argument of whether, for example, "No Significant Fault or Negligence" applies. The three-month ban could be reduced down to one month by completing a rehabilitation program satisfactory to the anti-doping organisation in question.

One expects this will be broadly welcomed by anti-doping organisations. However, there are concerns around the practicality and fairness of the proposed reduction to one month. For example, a substance abuse programme can often take a number of months to complete (unless it is a full-time residential programme), perhaps rendering the reduction redundant. In Ireland and presumably many other countries, such programmes are very often not immediately available and have lengthy waiting lists, again, by which time the reduction may be redundant. Finally, and perhaps most importantly, such programmes can be very costly indeed and so there would not be a level playing field for athletes that do not have significant resources.  

Recreational athletes

The draft 2021 Code seeks to add a new category of "Recreational Athletes", who would benefit from the same flexibility in sanctioning as minors, as provided in art. 14.3.6 – public disclosure would not be mandatory – and art. 10.5.1.3 – the minimum sanction would be a reprimand if "No Significant Fault or Negligence" is established.

The latest draft of the 2021 Code leaves it up to international federations, national anti-doping organisations and major event organisations to each identify who is a recreational athlete based on their own definitions of "international-level athletes" and "national-level athletes", subject to three overarching criteria, namely, that within the preceding five years the athlete:

  1. has not met the definition of national or international level athlete;
  2. has not represented a country in an international event; or
  3. has not been included within any international federation or national anti-doping organisation whereabouts information pool.

The introduction of this definition may be a significant administrative issue for national anti-doping organisations and international federations, in particular, and may have a number of unintended consequences. For example:

  1. National anti-doping organisations will have to change their definition of "national-level athlete". This will cause an unintended consequence as regards the WADA Technical Document for Sport Specific Analysis and retroactive TUE applications. The former requires a minimum level of analysis in relation to national level athletes, depending on the sport/discipline. Expanding the pool of athletes required to be subject to minimum level testing would substantially increase testing costs. Similarly, any expansion to the pool of national-level athletes could mean a significant increase in the number of TUE applications and the number of positive tests for which an athlete would currently be entitled to a retroactive TUE. 
  2. The question of who should be a recreational athlete will vary from sport to sport and country to country. One overarching definition will be extremely problematic and it will undoubtedly lead to inconsistencies.
  3. The wording in relation to representing a country in an international event may cause issues. Athletes competing in international events are not necessarily representing their country in doing so. This may vary significantly from sport to sport.
  4. The question of whether an athlete represented a country in an international event within the previous five years will have to be monitored by international federations and major event organisations and this information will have to be provided to national anti-doping organisations upon request.

Conclusion

While many proposed changes may be well-intentioned and good ideas in theory, the ever-increasing complexity of the Code may have the unintended consequence of smaller and less well-resourced anti-doping organisations dedicating more and more resources to managing and administering those increased layers of complexity. It remains to be seen if this will transpire. One of the stated purposes of the Code and the World Anti-Doping Programme is: "[t]o ensure harmonized, coordinated and effective antidoping programs at the international and national level with regard to detection, deterrence and prevention of doping."

The effectiveness of anti-doping programmes will remain a challenge and the changes proposed in the 2021 Code appear unlikely to prove materially more effective in catching and deterring doping in elite sport. However, the changes proposed do seek to address some areas of anti-doping programmes which may perhaps be seen as harsh on lower level athletes, in particular. They are, therefore, to be welcomed.

Footnotes

2 The process is described in detail here.

3 The Prohibited List, the International Standard for Testing and Investigations, the International Standard for Laboratories, the International Standard for Therapeutic Use Exemptions, the International

Standard for Protection of Privacy and Personal Information and the International Standard for Code Compliance for Signatories.

4 For example, the question of whether the potential to enhance performance should be a mandatory criterion for placing a substance on the Prohibited List has been the subject of significant debate since the Code first came into operation in 2003.

5 It is comprised of senior WADA staff and external experts; namely:

– Richard Young (Attorney, main drafter);
– Ulrich Haas (Professor of Law);
– Liz Riley (Attorney);
– Ben Sandford (Attorney and Member of WADA Athlete Committee);
– Tim Ricketts (WADA Director, Standards and Harmonization);
– Julien Sieveking (WADA Director, Legal Affairs); and
– Sébastien Gillot (WADA Director, European Regional Office and International Federations Relations).
6 2017 Anti-Doping Testing Figures, available at www.wada-ama.org/ sites/default/files/resources/files/2017_anti-doping_testing_figures_en_0.pdf (accessed 28 May 2019).

7 "Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys", available at https://link.springer.com/article/10.1007/s40279-017-0765-4 (accessed 28 May 2019).

8 "Doping proceedings against multiple NZ athletes", available at https://mch.govt.nz/doping-proceedings-against-multiple-nz-athletes (accessed 28 May 2019).

9 "Sports Tribunal has human rights concerns over anti-doping policing of low-level athletes", available at www.stuff.co.nz/sport/other-sports/111788685/sports-tribunal-has-human-rights-concerns-overantidoping-policing-of-lowlevel-athletes (accessed 28 May 2019).

10 "U.S. Cycling Athlete Carl Grove Accepts Public Warning", available at www.usada.org/carl-grove-accepts-public-warning (accessed 28 May 2019).

11 Decision Limits for the Confirmatory Quantification of Threshold Substances (WADA Technical Document – TD2018DL), available at www.wada-ama.org/sites/default/files/resources/files/td2018dl_v1_en.pdf (accessed 28 May 2019).

12 Chris Weller, "World Anti-Doping Agenct Raises Olympics' Marijuana Limits, Ups Positive Threshold From 15 Nanograms Per Millimeter To 150", in: Medical Daily, available at www.medicaldaily.com/world-anti-dopingagency-raises-olympics-marijuana-limits-ups-positive-test-threshold-15-nanograms (accessed 28 May 2019), and WADA, "New Threshold Level for Cannabis", available at www.wada-ama.org/en/media/news/2013-05/new-threshold-level-forcannabis (accessed 28 May 2019).

13 This is provided for in a comment to the definition of "No Significant Fault or Negligence".

14 Fault is defined as follows: "Fault is any breach of duty or any lack of care appropriate to a particular situation. Factors to be taken into consideration in assessing an Athlete or other Person's degree of Fault include, for example, the Athlete's or other Person's experience, whether the Athlete or other Person is a Minor, special considerations such as impairment, the degree of risk that should have been perceived by the Athlete and the level of care and investigation exercised by the Athlete in relation to what should have been the perceived level of risk. In assessing the Athlete's or other Person's degree of Fault, the circumstances considered must be specific and relevant to explain the Athlete's or other Person's departure from the expected standard of behavior. Thus, for example, the fact that an Athlete would lose the opportunity to earn large sums of money during a period of Ineligibility, or the fact that the Athlete only has a short time left in his or her career, or the timing of the sporting calendar, would not be relevant factors to be considered in reducing the period of Ineligibility under Article 10.5.1 or 10.5.2."

15 Art. 10.2.3 of the Code.

16 Please see by way of example the analysis in "Cocaine blues: What the Paolini case suggests about "recreational" drug use under the 2015 World Anti-Doping Code", available at http://wadc-commentary.com/paolini (accessed 28 May 2019).

17 Markus Manninen, "Doping: legal challenges posed by low concentration of a non-threshold substance", in: GSLTR 2018/4.

18 CAS 2009/A/1926 ITF v. Richard Gasquet, and CAS 2009/A/1930 WADAv. ITF & Richard Gasquet, Sport Dispute Resolution Center of Canada, decision SDRCC DT 16-0249, available at http://www.crdsc-sdrcc.ca/resource_centre/pdf/English/814_SDRCC_DT_16-0249.pdf (accessed 28 May 2019) and CAS 2017/A/5296 WADA v. Gil Roberts.

19 Art. 10.5.1.2 in combination with the definition of "No Significant Fault or Negligence".

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions